Literature DB >> 33895910

Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity.

Ying-Jian Gu1, Lei Chen1, Lin Cheng1, Ming-Yuan Zhou1, Yun Wang2.   

Abstract

Chronic exposure of the methamphetamine has been shown to lead to neurotoxicity in rodents and humans. The manifestations of methamphetamine neurotoxicity include methamphetamine use disorder, methamphetamine abuse, methamphetamine addiction and methamphetamine behavioral sensitization. Repeated use of methamphetamine can cause methamphetamine use disorder. The abuse and addiction of methamphetamine are growing epidemic worldwide. Repeated intermittent exposure to methamphetamine can cause behavioral sensitization. In addition, many studies have shown that changes in the expression of non-coding RNA in the ventral tegmental area and nucleus accumbens will affect the behavioral effects of methamphetamine. Non-coding RNA plays an important role in the behavioral effects of methamphetamine. Therefore, it is important to study the relationship between methamphetamine and non-coding RNA. The purpose of this review is to study the non-coding RNA associated with methamphetamine neurotoxicity to search for the possible therapeutic target of the methamphetamine neurotoxicity.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Addiction; Drug abuse; Locomotor sensitization; Methamphetamine; Neurotoxicity; Non-coding RNA; Use disorder

Year:  2021        PMID: 33895910     DOI: 10.1007/s11010-021-04160-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

1.  Human pharmacology of the methamphetamine stereoisomers.

Authors:  John Mendelson; Naoto Uemura; Debra Harris; Rajneesh P Nath; Emilio Fernandez; Peyton Jacob; E Thomas Everhart; Reese T Jones
Journal:  Clin Pharmacol Ther       Date:  2006-10       Impact factor: 6.875

Review 2.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Authors:  Daniel Ciccarone
Journal:  Prim Care       Date:  2011-01-11       Impact factor: 2.907

3.  Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Authors:  Y Sekine; M Iyo; Y Ouchi; T Matsunaga; H Tsukada; H Okada; E Yoshikawa; M Futatsubashi; N Takei; N Mori
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

4.  Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Masami Futatsubashi; Hiroyuki Okada; Yoshio Minabe; Katsuaki Suzuki; Yasuhide Iwata; Kenji J Tsuchiya; Hideo Tsukada; Masaomi Iyo; Norio Mori
Journal:  Arch Gen Psychiatry       Date:  2006-01

5.  Further pharmacological comparison of D-methamphetamine and L-methamphetamine in rats: abuse-related behavioral and physiological indices.

Authors:  Zhaoxia Xue; Justin N Siemian; Qing Zhu; Bruce E Blough; Jun-Xu Li
Journal:  Behav Pharmacol       Date:  2019-08       Impact factor: 2.293

6.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Authors:  J M Wilson; K S Kalasinsky; A I Levey; C Bergeron; G Reiber; R M Anthony; G A Schmunk; K Shannak; J W Haycock; S J Kish
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

7.  l-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine.

Authors:  W P Melega; A K Cho; D Schmitz; R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

8.  Why is parkinsonism not a feature of human methamphetamine users?

Authors:  Anna Moszczynska; Paul Fitzmaurice; Lee Ang; Kathryn S Kalasinsky; Gregory A Schmunk; Frank J Peretti; Sally S Aiken; Dennis J Wickham; Stephen J Kish
Journal:  Brain       Date:  2003-11-25       Impact factor: 13.501

9.  Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine.

Authors:  R Kuczenski; D S Segal; A K Cho; W Melega
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

View more
  1 in total

Review 1.  Epigenetic Effects of Addictive Drugs in the Nucleus Accumbens.

Authors:  Ethan M Anderson; Makoto Taniguchi
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.